Raltegravir use in real life – 1 year data in HIV multi-experienced patients

A. Carlebach, F. Berger, A. Mueller, G. Knecht, P. Gute, T. Lutz & S. Mauss
Aims: Raltegravir (RAL) has shown considerable potency and safety in several clinical trials. We evaluate the efficacy of raltegravir containing antiretroviral (ARV) regimens in HIV+ patients with several treatment failures in "real life". Methods: Cohort of consecutively enrolled [for full text, please go to the a.m. URL]